A polypill that includes key medications associated with improved outcomes (aspirin, angiotensin-converting–enzyme [ACE] inhibitor, and statin) has been proposed as a simple approach to the secondary ...
The first clinical trial to challenge the routine implantation of a defibrillator in myocardial infarction survivors with heart failure has enrolled its first patient. The PROFID EHRA trial is part of ...
It has come to light that there are irregularities in a clinical trial published by The BMJ on 29 October 2025: Prevention of acute myocardial infarction induced heart failure by intracoronary ...
After nonfatal myocardial infarction or stroke, initiation of a GLP-1 receptor agonist was linked to reduced risk for all-cause and CV-related mortality in patients with diabetes, researchers reported ...
Coverage of a new PCSK9 trial makes bold claims about prevention and risk reduction. But how well do they hold up to scrutiny ...
In a recent study published in the journal Nature Cardiovascular Research, researchers developed and validated a novel biomarker-based prediction model to evaluate imminent first myocardial infarction ...
Credit: Getty Images A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD. Beta blockers have long been included in the ...
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below: Receive the the latest news, research, and presentations from major meetings ...
Myocardial ischemia, also called cardiac ischemia, is a condition characterized by reduced blood flow to the heart. A common cause is plaque buildup in the coronary arteries. Myocardial ischemia may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results